These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 17041596)

  • 21. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.
    Brooks DG; Lee AM; Elsaesser H; McGavern DB; Oldstone MB
    J Exp Med; 2008 Mar; 205(3):533-41. PubMed ID: 18332180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo.
    Blattman JN; Grayson JM; Wherry EJ; Kaech SM; Smith KA; Ahmed R
    Nat Med; 2003 May; 9(5):540-7. PubMed ID: 12692546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression.
    Bergthaler A; Flatz L; Hegazy AN; Johnson S; Horvath E; Löhning M; Pinschewer DD
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21641-6. PubMed ID: 21098292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions.
    Fuse S; Molloy MJ; Usherwood EJ
    Crit Rev Immunol; 2008; 28(2):159-83. PubMed ID: 18540829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-10: achieving balance during persistent viral infection.
    Ng CT; Oldstone MB
    Curr Top Microbiol Immunol; 2014; 380():129-44. PubMed ID: 25004816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive mechanisms during viral infectious diseases.
    Sarikonda G; von Herrath MG
    Methods Mol Biol; 2011; 677():431-47. PubMed ID: 20941625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular basis of IL-10 function: from receptor structure to the onset of signaling.
    Walter MR
    Curr Top Microbiol Immunol; 2014; 380():191-212. PubMed ID: 25004819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Light-base technology to neutralize viral infections.
    Bagnato VS; Pinheiro A; Baptista MS
    J Photochem Photobiol; 2022 Sep; 11():100119. PubMed ID: 35378973
    [No Abstract]   [Full Text] [Related]  

  • 29. Blockade of chronic type I interferon signaling to control persistent LCMV infection.
    Wilson EB; Yamada DH; Elsaesser H; Herskovitz J; Deng J; Cheng G; Aronow BJ; Karp CL; Brooks DG
    Science; 2013 Apr; 340(6129):202-7. PubMed ID: 23580528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular signature of CD8+ T cell exhaustion during chronic viral infection.
    Wherry EJ; Ha SJ; Kaech SM; Haining WN; Sarkar S; Kalia V; Subramaniam S; Blattman JN; Barber DL; Ahmed R
    Immunity; 2007 Oct; 27(4):670-84. PubMed ID: 17950003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-10 directly suppresses CD4 but not CD8 T cell effector and memory responses following acute viral infection.
    Brooks DG; Walsh KB; Elsaesser H; Oldstone MB
    Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3018-23. PubMed ID: 20133700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistent LCMV infection is controlled by blockade of type I interferon signaling.
    Teijaro JR; Ng C; Lee AM; Sullivan BM; Sheehan KC; Welch M; Schreiber RD; de la Torre JC; Oldstone MB
    Science; 2013 Apr; 340(6129):207-11. PubMed ID: 23580529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of IL-10 in regulating immunity to persistent viral infections.
    Wilson EB; Brooks DG
    Curr Top Microbiol Immunol; 2011; 350():39-65. PubMed ID: 20703965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and cellular insights into T cell exhaustion.
    Wherry EJ; Kurachi M
    Nat Rev Immunol; 2015 Aug; 15(8):486-99. PubMed ID: 26205583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-21 is required to control chronic viral infection.
    Elsaesser H; Sauer K; Brooks DG
    Science; 2009 Jun; 324(5934):1569-72. PubMed ID: 19423777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection.
    Brooks DG; Ha SJ; Elsaesser H; Sharpe AH; Freeman GJ; Oldstone MB
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20428-33. PubMed ID: 19075244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-10: the master regulator of immunity to infection.
    Couper KN; Blount DG; Riley EM
    J Immunol; 2008 May; 180(9):5771-7. PubMed ID: 18424693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T cell exhaustion.
    Wherry EJ
    Nat Immunol; 2011 Jun; 12(6):492-9. PubMed ID: 21739672
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-10 Directly Inhibits CD8
    Smith LK; Boukhaled GM; Condotta SA; Mazouz S; Guthmiller JJ; Vijay R; Butler NS; Bruneau J; Shoukry NH; Krawczyk CM; Richer MJ
    Immunity; 2018 Feb; 48(2):299-312.e5. PubMed ID: 29396160
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.